Our Technologies

Read about our available technologies and get in touch with our team

Filter

Sectors

Industries

Clear all filters

Alternative methods for particle jamming to create simulated hardness in haptic feedback devices at lower cost compared to pneumatic systems
A seeding amplification assay with spatial resolution that visualises protein misfolding and aggregation in intact biological samples to study the mechanisms of neurodegeneration and cross-seeding between diseases.
Mass spectrometry assay measuring 3'-deoxy-3',4'-didehydro-cytidine (ddhC) to quantitatively detect active viral infections
Seamless integration of large nitrogen fixation clusters into virtually any bacterial strain – unlocking exciting new frontiers in biofertilisers
Advanced real-time defect characterization for semiconductors, including imaging sensors, optical sensors, and photovoltaics
Accurate quantification of cardiac anatomy and function using sparse 2D echo images achieved with an algorithm that reconstructs 3D model from 2D images.
LhARA is a Laser hybrid Accelerator for Radiobiological Applications in which laser interactions drive the creation of a large flux of protons or light ions.
A new way to manufacture antimicrobial polymers in which an anti-microbial agent is blended into a polymer matrix through melt blending.
Utilising peptides derived from healthy human gut microbiome, this technology offers potential therapeutic applications in treating disorders related to mood, behaviour, and gastrointestinal function by modulating the gut-brain axis.

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Licensing and IP performance 2019/20

Inventions disclosed

Imperial inventors submitted 250 invention disclosures to our IPC team during the year

Active licences

Imperial College London's licensing portfolio comprises 244 licences

Patents filed

Imperial filed 137 patents (including PCT applications) during the year

Patent portfolio

Imperial's patent portfolio reached 331 patents during the year

Upcoming Events

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Latest News

Accelerated development of a potential treatment for cystic fibrosis

Accelerated development of a potential treatment for cystic fibrosis

The UK Cystic Fibrosis Gene Therapy Consortium (GTC) is one of the partners in a licensing agreement with Boehringer Ingelheim. Find out more

Natural Killer – licensing a cell therapy

Natural Killer – licensing a cell therapy

Imperial has licensed iNKT cell technology based on research by Prof. Tassos Karadimitris to SUDA Pharmaceuticals. Find out more

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial partner Apollo receives £100m to boost medical research at leading unis

Imperial will benefit from continued support for translational biomedical research under a unique technology transfer model. Find out more

Loading...